SUPERNUS PHARMACEUTICALS INC earnings per share and revenue

S49 earnings per share for the last quarter are 0.72 EUR whereas the estimation was 0.50 EUR which accounts for 43.54% surprise. Company revenue for the same period amounts to 168.23 M EUR despite the estimated figure of 149.97 M EUR. Estimated earnings per share for the next quarter are 0.36 EUR, and revenue is expected to reach 139.73 M EUR. Also watch annual changes over time to get a bigger picture of S49 earnings per share and revenue dynamics.